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Abstract
The regenerative capacity of skeletal muscle declines with age. Previous studies suggest that this 
process can be reversed by exposure to young circulation, but systemic age-specific factors 
responsible for this phenomenon are largely unknown. Here we report that oxytocin- a hormone 
best known for its role in lactation, parturition, and social behaviors - is required for proper muscle 
tissue regeneration and homeostasis, and that plasma levels of oxytocin decline with age. 
Inhibition of oxytocin signaling in young animals reduces muscle regeneration, whereas systemic 
administration of oxytocin rapidly improves muscle regeneration by enhancing aged muscle stem 
cell activation/proliferation throughactivation of the MAPK/ERK signalling pathway. We further 
show that the genetic lack of oxytocin does not cause a developmental defect in muscle, but 
instead leads to premature sarcopenia. Considering that oxytocin is an FDA approved drug, this 
work reveals a potential novel and safe way to combat or prevent skeletal muscle aging.
INTRODUCTION
The proportion of people over the age of 60 is growing faster than any other age group, as a 
result of both longer life expectancy and declining fertility rates, thus enhancing the quality 
of life as age of people is of major importance. With aging, the capacity of our tissues to 
maintain homeostasis and regenerate declines and eventually fails, leading to degenerative 
disorders and eventual organ failure. The reduction in muscle mass in humans starts in the 
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third decade of life and accelerates after the fifth decade, resulting in a decrease in strength 
and agility1. Muscle aging is characterized by a deficiency in muscle regeneration after 
injury and by muscle atrophy associated with altered muscle function, defined as 
sarcopenia2. The limiting step in muscle regeneration after injury is the activation of the 
muscle stem cells, or satellite cells. They need to break quiescence and proliferate in order to 
form new myofibers or fuse with damaged ones. Satellite cells from old muscle are 
intrinsically able to repair damaged muscle, but are reversibly inhibited by the aged niche, 
yet can be quickly rescued for productive tissue repair by a number of experimental 
methods, including heterochronic parabiosis3. While the rejuvenating effects of 
heterochronic parabiosis have been observed in several tissues such as muscle, brain, liver, 
pancreas, and heart4-9 the molecular mechanisms are not fully understood and only a few 
potential systemic factors responsible for this phenomena have been identified. A few pro-
aging circulating factors which increase in old animals have been identified, including TGF-
β and Wnt signaling pathway effectors, which are deleterious for muscle regeneration5,10, as 
well as the CCL11 chemokine that leads to impaired neurogenesis and decreased cognition 
and memory6. To date, few circulating molecules decreasing with age have been identified 
to be responsible for skeletal muscle aging
Considering that oxytocin (OT) levels decrease after ovariectomy, which mimics hormonal 
aging11 and that myoblasts express the oxytocin receptor (OTR)12, we hypothesized that OT 
might be among the key circulating age-specific determinants of maintenance and repair of 
skeletal muscle. OT is a nonapeptide mainly produced by the hypothalamus and stored in the 
neurohypophysis. It acts via its receptor both centrally as a neuromodulator and peripherally 
as a hormone, released by the neurohypophysis into the circulation. The OTR is a class I G-
protein-coupled receptor, which upon OT binding activates protein kinase C and induces 
intracellular calcium release that acts as a second messenger to induce a cascade of 
intracellular changes and activity13. OT is best known for its role in lactation and 
parturition14 as well as in social behaviors, promoting trust and bonding15. While the role of 
OT in supporting tissue homeostasis and regeneration is poorly documented, recent 
published work proposed a role of OT in preventing osteoporosis and obesity11,16-20 and in 
improving myocardium recovery after ischemic injury21. Additionally, OT has been shown 
to facilitate in vitro differentiation of mesenchymal stem cells toward cardiomyogenesis and 
osteogenesis and to inhibit adipocyte differentiation11,22.
Here we show that plasma levels of oxytocin and the levels of oxytocin receptor in muscle 
stem cells dramatically decline with age and demonstrate that oxytocin is required for 
skeletal muscle tissue regeneration and homeostatic maintenance. Importantly, we show that 
short-term systemic OT delivery restores muscle regeneration in old mice by improving 
aged muscle stem cell function, while pharmacologic attenuation of OT signaling with a 
selective antagonist alters muscle regeneration in young mice. Confirming the dependence 
of muscle maintenance and repair on oxytocin, mice deficient for Ot present signs of 
premature muscle tissue aging: defective muscle regeneration and a decrease in muscle mass 
and fiber size characteristic of sarcopenia at only 12 months of age. Our results suggest that 
OT per se or deliberate modulation of OT signaling could become a potential treatment to 
combat the age-related decline in muscle tissue maintenance and repair.
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RESULTS
Systemic OT and OTR levels in satellite cells decline with age
Since circulating OT levels decrease after ovariectomy, which mimics hormonal aging11, we 
hypothesized that its level would decrease during natural aging. OT plasma levels were 
measured in young (2-4 month old) and old (18-24 month old) C57/BL6 male mice, using 
an OT-specific enzyme immunoassay. A significant 3-fold decrease was observed in aged 
mice as compared to young, suggesting that endocrine levels of OT decline with age (Fig. 
1a). Little is known about the expression of the oxytocin receptor (OTR) in skeletal muscle 
either in general or in an age-specific way; thus we examined OTR protein expression in 
young and old skeletal muscle. Western blotting analysis demonstrates that OTR is detected 
in whole skeletal muscle (Fig 1b). Similar levels of OTR were observed in young and old 
whole muscle lysates that contain, in addition to proteins from muscle fibers and satellite 
cells, proteins from other cell types including vascular and immune cells, adipocytes and 
fibroblasts (Fig. 1b, d). Notably, when protein lysates were prepared from muscle stem cells, 
OTR was found to be expressed at significantly higher levels in young satellite cells as 
compared to old (Fig. 1c, e). These results demonstrate that with aging the decline in the 
circulating OT hormone is compounded by diminished levels of OTR in the old muscle stem 
cells. Confirming the western blotting data, immunofluorescence analysis of muscle tissue 
sections revealed that OTR was indeed expressed in cells that were observed in the satellite 
cell position (Fig. 1f, top) and co-localized with the satellite cell marker Pax7 in quiescent 
and injury-activated satellite cells (Fig. 1f, middle panels). Although most Pax7-positive 
satellite cells express OTR, expression of this receptor was also observed in many Pax7-
negative cells (Fig. 1f), suggesting that OT acts on several cell types in skeletal muscle.
Systemic decline in OT causes poor regeneration of old muscle
To determine whether the age-specific decrease in systemic OT is responsible for the decline 
in muscle regeneration that is typical of old mice, we systemically administered OT to old 
mice and an OT-selective antagonist (OTA) to young mice and studied the success in 
muscle regeneration after cardiotoxin-induced injury. The schematic for this study is shown 
in Figure 2a. Five days post injury, robust muscle regeneration was observed in young mice, 
based on the high numbers of newly-formed (eMyHC+) fibers with centrally-located nuclei 
in the injured area (Fig. 2b, c). As expected, a significant decline in the formation of new 
muscle fibers was evident in old mice. Interestingly, subcutaneous injections of OT 
improved muscle regeneration in the old mice to a level comparable to the young. In young 
mice, in which muscle regeneration occurs efficiently, ectopic OT had no effect (Fig. 2b, c). 
Importantly, a significant decrease in muscle regeneration, to a level similar to that seen in 
old mice, ensued when young mice were administered with OTA (Fig. 2b, c).
The deficiency in skeletal muscle regeneration observed in aged mice is associated with an 
increase in fibrotic tissue formation5,23. As expected, the fibrotic index was greater in old 
mice as compared with young (Fig. 2d and Supplementary Fig. 1a). Ectopic OT significantly 
decreased the fibrotic index in old mice, whereas OTA injections increased fibrosis in young 
mice (Fig. 2d and Supplementary Fig. 1a).
Elabd et al. Page 3
Nat Commun. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
These data demonstrate that one consequence of the age-specific systemic decline in OT is 
poor regeneration of skeletal muscle accompanied by increased fibrosis. Importantly, 
ectopic OT rapidly rescued repair of damaged old muscle, while OTA quickly incapacitated 
the regeneration of young muscle.
OT mediates the regenerative potential of muscle stem cells
Satellite cell activation/proliferation are the main limiting steps in old muscle regeneration. 
Exposure to a young environment has been shown to restore muscle regeneration by 
promoting satellite cell proliferation3,4,24. Since ectopic OT exposure over a short period of 
time rescued the repair of damaged old muscle, we evaluated whether the decreased level of 
OT in old was responsible for the lack of satellite cell proliferation in vivo. OT was 
administered to old mice daily starting 6 days prior to cardiotoxin-induced muscle injury 
(Fig. 3a). To monitor cell division in vivo, BrdU was injected subcutaneously 12 hours prior 
to euthanasia. Three days after injury, tibialis anterior muscles were isolated, and the 
percentages of BrdU and Desmin double positive cells (i.e. proliferating myogenic 
progenitor cells that were generated by satellite cells activated in response to tissue injury) 
were quantified in the injury area in muscle sections (Fig. 3b, c). As we have previously 
published, these myogenic cells co-express Pax7 and Desmin, while the non-myogenic 
Desmin-positive cells represent less than 2% in such experiments25,26. A 3-fold decrease in 
myogenic cell proliferation was observed in old muscles as compared with young (Fig. 3c). 
Importantly and in agreement with the rescue of muscle repair, ectopic OT significantly 
improved myogenic cell proliferation in vivo (Fig. 3c).
To further study the effect of OT on satellite cell proliferation and differentiation, we 
performed an ex vivo analysis, as described in the schematic of Figure 4a. Three days post 
injury, muscles were isolated and digested into bulk myofibers as previously 
described4,24,25,27 and cells were cultured in their own mouse’s respective serum for 24 
hours (Fig. 4a). In order to label the cells that were activated in vivo in response to muscle 
injury, BrdU was injected subcutaneously 12 hours prior to euthanasia. Myogenic 
proliferation of cells activated in vivo was quantified by calculating the percentage of BrdU 
and Desmin double positive cells, which as mentioned above is a sensitive and accurate way 
to measure the age-specific differences in myogenicity24,25,27. A 41% decrease in 
proliferation was observed in the old activated satellite cells as compared with young (Fig. 
4b, c). Confirming the in vivo data observed in Figure 3c, ectopic OT restored the myogenic 
proliferation of old satellite cells to a level comparable to young. Moreover, decreased 
myogenic proliferation was observed when young mice were treated with OTA (Fig. 4b, c). 
We also observed that the proliferation of activated satellite cells derived from young mice 
administered with OT tended to increase.
To study whether these Brdu and Desmin double-positive satellite cell progeny were 
functionally competent, we evaluated their myogenic differentiation potential. As illustrated 
in Figure 4a, cells isolated from muscles at 3 days post injury were cultured for 24 hours in 
their mouse’s respective serum and were switched to differentiation medium for 48 hours, 
when a pronounced age-specific decline in generation of de-novo myotubes is typically 
detected. The myogenic fusion index (the number of nuclei included in de novo formed 
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eMyHC+ myotubes as a fraction of the total nuclei), was then scored to assess cell 
differentiation. Supporting the observed increase in the number of newly-regenerated 
eMyHC+ fibers in vivo after OT injection (Fig. 2b, c), systemic administration of OT to old 
mice rejuvenated the myofiber-forming capacity of satellite cells responding to tissue injury 
(Fig. 4d, e). In agreement with the idea that OT is required for myogenicity, when OT 
signaling was antagonized in young mice not only the proliferation but also the 
differentiation declined to levels similar to those of old animals, with their low circulatory 
OT (Fig. 4d, e). These results demonstrate that myogenic proliferation and subsequent 
differentiation depend on “youthful” levels of OT.
Since we showed that OTR was expressed in skeletal muscle satellite cells (Fig. 1c, e and f), 
we hypothesized that OT acts directly on myogenic cells. To test this hypothesis, satellite 
cells were freshly isolated from cardiotoxin-injured muscles and plated in medium 
containing their own mouse serum supplemented or not with OT for 24 hours. As previously 
published28 and shown in Supplementary Figure 2, satellite cell purity was similar for young 
and old cells and greater than 90%. OT increased the proliferative capacity of old satellite 
cells cultured in old serum to similar levels of young cells cultured in young serum, as 
shown by the increased percentage of Ki67 positive activated muscle stem cells and the 
diminished expression of the cyclin-dependent kinase inhibitor 1, p21 (Fig. 5a-c). No effects 
of OT were observed on young satellite cells, in agreement with the higher levels of 
endogenous OT in young circulation (Fig. 1a). OT also promoted the proliferation of 
primary myogenic progenitors as shown by a three-fold increase in the percentage of BrdU 
positive cells (Fig. 5d, e).
OT directly acts in satellite cells via the MAPK/ERK pathway
Since the MAPK signaling pathway plays an important role in muscle stem cell activation/
proliferation29-34 and phospho-ERK1/2 is a well-documented downstream effector of OT in 
other cell types11,35, we postulated that OT could be a physiological inducer of MAPK, that 
promotes myogenic cell proliferation via the phosphorylation of ERK1/2. Indeed, addition 
of a MEK inhibitor (MEKi) decreased the proliferation of young satellite cells and increased 
the expression of p21 to old levels (Fig. 5a-c). In accordance with the idea that OT signals 
via MAPK in supporting adult myogenesis, the effects of ectopic OT on freshly isolated 
activated satellite cells and on primary myogenic progenitor cells were abolished in the 
presence of MEKi (Fig. 5a-e).
To confirm the ability of OT to induce ERK1/2 phosphorylation, primary myogenic 
progenitor cells were stimulated for 5 to 20 minutes with OT in the presence or absence of 
MEKi. ERK1/2 phosphorylation was greatly induced 5 minutes after stimulation with OT 
(Fig. 5f). At 10 minutes ERK1/2 phosphorylation started to decrease and returned to the 
basal level by 20 minutes (Fig. 5f). In support of functional effects of OT on myogenic cell 
proliferation shown above, MEKi prevented OT-induced ERK1/2 phosphorylation, reducing 
the levels of phospho-ERK1/2 below the basal level observed in untreated cells (Fig. 5f), all 
confirming activation of the MAPK pathway by its endogenous ligand for productive 
myogenic responses.
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Ot deficient mice display premature muscle aging
To confirm these findings in a genetic model, we studied muscle regeneration after 
cardiotoxin-induced injury in Ot knockout (KO) mice (B6;129S-Oxttm1Wsy/J). As 
compared to their wild type (WT) littermates, we observed a progressive decline in muscle 
regeneration of Ot KO mice that was noticeable at 3 months of age and became pronounced 
and significant at 12 months of age (Fig. 6a, b). The decline in muscle regeneration observed 
between one year old WT and Ot KO mice is comparable to the one measured between 
young (2-4 month old) and old (18-24 month old) WT C57/BL6 mice. In accordance with 
the data on the in vivo decline in the myogenic cell proliferation in old C57/BL6 mice, a 
decrease in activated satellite cell proliferation was observed in Ot KO mice when compared 
to WT littermates (Fig. 6c). A significant decline in muscle maintenance and repair is not 
expected and was not observed in WT mice at 12 months of age (Fig. 6b); thus it is very 
interesting that the lack of OT prematurely ages the animals in this aspect.
Moreover, similarly to 24-month-old C57/BL6 old mice, 12-month-old Ot KO mice display 
prematurely increased fibrosis when compared to age-matched WT littermates (Fig. 6d, 
Supplementary Fig. 1b). Appearance of adipocytes within the injured area has been reported 
to occur after muscle injury36-39. The number of adipocytes within the recently regenerated 
or un-injured muscle (assayed by perilipin staining), was generally low and a non-significant 
increase was observed in Ot KO mice, as compared with WT animals (Fig. 6e-g). However, 
we observed a clear increase in perimuscular and intermuscular adipose tissue deposition 
around the hind limb muscles in Ot KO versus WT littermates (Fig. 7a), consistent with the 
overall adipose tissue mass increase17.
Muscle aging is characterized by a deficiency in muscle regeneration after injury but, most 
importantly, by muscle atrophy and altered muscle function observed in older individuals 
and defined as sarcopenia1,2. Having demonstrated that a lack of OT resulted in the 
diminished regeneration of old muscle after injury we next sought to examine whether OT 
was involved in age-associated sarcopenia. To test this hypothesis, we assessed the mass of 
the gastrocnemius and the tibialis anterior muscles of 12-month-old Ot KO mice and their 
WT littermates. As shown in Figure 7b and c, Ot deficiency resulted in significantly smaller 
muscles: Ot KO mice displayed a 32% decrease in muscle mass for the tibialis anterior and a 
22% decrease for gastrocnemius as compared to their WT littermates. We further compared 
the muscle histology of Ot KO versus WT mice by measuring muscle fiber surface area as 
well as the minimum Feret diameter of muscle cross section. Remarkably, there was a 
significant decrease in both the surface area and the minimum Feret diameter in Ot KO as 
compared to WT mice (Fig. 7d, e). Importantly, no difference was observed in the fiber 
surface area or in the minimum Feret diameter between WT and Ot KO mice when 
compared at 3 months of age, demonstrating that the muscle atrophy observed in Ot 
deficient mice at 12 months of age was not a consequence of a developmental defect (Fig. 
7d, e). These data demonstrate that the KO in Ot is the first known genetic defect that results 
in premature sarcopenia and suggest that in the absence of OT, the non-significant but 
noticeable decline in muscle regeneration observed at 3 months of age might contribute to 
the decline in muscle fiber size and increased fibrosis and fat deposition by 12 months of 
age (Fig. 6b).
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DISCUSSION
The role of OT in tissue homeostasis and regeneration is poorly documented and age-
specific OT studies are lacking. The present work is the first to demonstrate that OT 
supports productive repair and maintenance of skeletal muscle, and that age-imposed decline 
in OT contributes to sarcopenia. Moreover, we show that OT acts directly on muscle stem 
cells (in vitro and in vivo) and that pro-myogenic effects of OT are mediated by 
MAPK/ERK signalling.
The age-specific decrease in OT receptor levels in muscle stem cells compounds the decline 
of OT itself, but importantly, significant OT receptor levels still remain in the old cells, 
allowing for an enhancement of myogenesis by ectopic OT. Interestingly, these findings are 
a mirror image of the age-imposed deregulation of TGF-beta/pSmad3 signaling in muscle 
stem cells, where with age there is an up-regulation of TGF-beta1 and simultaneous 
elevation of the TGF-beta receptor24,40. The concordant deregulation of receptors in muscle 
stem cells (and perhaps in tissue stem cells in general), and of the specific ligands (locally 
and / or in circulation) might be an interesting commonality of the aging process.
The conclusion of a pivotal role of OT in the age-specific regulation of myogenesis is 
emphasized by the agreement between pharmacological and genetic studies. Even though Ot 
KO mice could have developed compensations for the lack of OT and the high levels of 
myogenic IGF1, GH, etc. factors that are present in these animals at a young age there is 
already a tendency toward a decline in muscle regenerative capacity in Ot KO mice at 3 
months of age. Such a decline is clearly manifested upon an acute administration of OT 
antagonist to young C57/BL6 animals. Prolong constant attenuation of muscle regeneration 
might contribute to premature decrease in muscle tissue health, which we observe by 1 year 
in Ot KO mice. While OT is a multifunctional hormone and future comprehensive work is 
needed in order to uncover its many age-specific effects on cells and tissues, this study 
strongly suggest that the lack of OT causes decline in myogenic responses of satellite cells, 
leading to an abandonment of muscle tissue maintenance.
Considering that during normal aging ubiquitin-proteasome proteolysis does not seem to 
cause the age-related muscle atrophy and that in contrast, muscle hypertrophy and healthy 
functionality cannot be sustained without effective tissue remodeling41-43, the contribution 
of the age-specific decline in OT to the lack of myogenicity is a significant factor in muscle 
aging. Importantly, no deterioration of muscle tissue or decrease in myofiber size have been 
detected in the 3-month-old Ot KO mice, suggesting that the genetic lack of Ot does not 
cause a developmental defect, and instead specifically exacerbates sarcopenia.
To date, no effective treatment is available to treat or prevent sarcopenia and the primary 
recommendation remains exercise. Our work suggests that OT represents a physiological 
systemically present inducer of satellite cell activation/proliferation and hence, that systemic 
delivery of OT can counteract the defects in regeneration and maintenance of old muscle, 
which develop in part due to the age-specific decline in this hormone.
Our results demonstrate that OT is one of the key age-specific systemic regulators of muscle 
maintenance and repair; however, it is unlikely that only one circulating molecule accounts 
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for systemic aging or rejuvenation and other cell fate regulatory pathways have been shown 
to participate in these phenomena5,24. While other strategies such as long-term activation of 
the Notch signaling pathway or down-regulation of the TGF-β/pSmad and Wnt signaling 
pathways have been shown to be successful in acute rejuvenation of myogenesis4,5,24 they 
come with side-effects such as oncogenic transformations, inadequate hematopoiesis, broad 
immune deregulation, etc. Therefore therapeutic modulation of key regulatory pathways is 
not an easy task. In contrast, OT is a naturally-produced endocrine peptide that has little to 
no known detrimental side effects. Diminished circulating levels of OT are associated with 
pathological states such as autism in children44,45, osteoporosis46, and depression47. OT is 
approved for use in women during parturition, has been tested to improve psychological 
well-being in the elderly48, and is in clinical trials to treat autism, schizophrenia, and 
depression. Because of its size and structure, OT can be administered easily and by multiple 
routes such as by intra-nasal inhalation. The potent positive effects of OT on muscle tissue 
homeostasis and repair that were uncovered in this study are thus promising for developing 
an effective and safe new clinical strategy where OT and OTR agonists might be potentially 
used as systemically applicable, and sustainable molecules for combating the deterioration 
of muscle mass, strength, and agility in the elderly.
METHODS
Plasma preparation and oxytocin quantification
Whole blood was collected into a citrate-treated tube and spun at 700 g for 15 minutes to 
remove cells. Supernatant was transferred to a second citrate-treated tube, spun at 1500 g for 
20 minutes to remove platelets. Plasma was aliquoted and stored at −80°c. Plasma OT 
concentration was measured using an Enzyme Immunoassay kit (Bachem, S-1355) 
according to the manufacturer’s recommendation.
Animals
8-week-old male C57BL/6 mice and B6;129S-Oxttm1Wsy/J mice were purchased from the 
Jackson Laboratory. 22-month-old male C57BL/6 mice were purchased from the National 
Institute on Aging. Animals were housed and B6;129S-Oxttm1Wsy/J mice were bred at the 
Northwest Animal Facility (University of California, Berkeley). All procedures were 
performed in accordance with the administrative panel of the Office of Laboratory Animal 
Care, UC Berkeley. Sample size for each experiment was determined based on previously 
published differences between control young versus old animals in order to have sufficient 
statistical power, using the minimum necessary number of mice. The protocol was approved 
by the UC Berkeley Animal Care and Use Committee (ACUC). Mice were anesthetized by 
isoflurane drop and killed by cervical dislocation; blood samples were collected by heart 
puncture. Mice were injected daily with 50 μL of OT (1 μg g−1 of mice), OTA (2 μg g−1 of 
mice), or vehicle (HBSS) by interscapular subcutaneous injections.
Satellite cell preparation and cell culture
Tibialis anterior and gastrocnemius muscles of mice were injected with a total of 10 μg of 
cardiotoxin (Sigma-Aldrich) per leg dissolved in PBS or were left uninjured. Muscles were 
dissected 3 days post injury and satellite cells were derived as previously described4,24,25. 
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Briefly, harvested muscles underwent enzymatic digestion in DMEM (Mediatech) 
containing collagenase type II (250 U mL−1; Sigma-Aldrich), 10 mM HEPES, and 
penicillin/streptomycin antibiotics (500 IU mL−1, 0.1 mg mL−1; MP Biomedicals) at 37 °C 
for 1 hour under agitation. Fat pads and tendons were removed after a quick wash with PBS 
and repeated rounds of muscle trituration and sedimentation were performed to purify 
myofibers. Myofibers were either plated or incubated with collagenase type II (40 U mL−1, 
Sigma-Aldrich) and dispase (2 U mL−1; Invitrogen) diluted in Ham’s F-10 (Mediatech), 
supplemented with 10% horse serum, and penicillin/streptomycin at 37 °C for 1 hour and 30 
minutes under agitation. Suspensions were vortexed for 1 minute to release satellite cells 
from digested fibers, passed through a 40-μm cell strainer (BD Biosciences) and pre-plated 
on uncoated dishes for 20 minutes at 37 °C, 5% CO2. Cells that did not adhere during pre-
plating were collected and plated onto Matrigel-coated (BD Biosciences) CC2-treated 
chamber slides (LabTek II, Thermo Fisher Scientific) in DMEM supplemented with 10% 
sera from the mouse they came from. Myofibers were plated in Opti-MEM (Gibco) 
supplemented with 10% sera from the mouse they came from for 24 hours. Myofibers were 
then washed away and cells were either fixed for staining or induced to differentiate in the 
presence of DMEM 2% horse sera for 48 hours. Primary myogenic progenitors were 
cultured in growth medium composed of Ham’s F10 (Mediatech), penicillin/streptomycin 
antibiotics (500 IU mL−1, 0.1 mg mL−1; MP Biomedicals), and 20% Bovine Growth Serum 
(Life Technologies/Hyclone), supplemented with FGF-2 (6 ng mL−1). To monitor the effect 
of OT on primary myogenic progenitor cell proliferation, cells were cultured in growth 
medium supplemented with OT (30 nM) alone or in combination with UO126 MEK 
inhibitor (10 μM). For ERK1/2 phosphorylation kinetics, primary myogenic progenitors 
were starved for 16 hours in Opti-MEM (Gibco) before stimulation with, OT (30 nM) alone 
or in combination with UO126 MEK inhibitor (10 μM) for 5, 10, 15, and 20 minutes.
Western blotting
Cells were lysed in RIPA buffer containing a protease inhibitor cocktail (Complete, Roche), 
PMSF, NaF, β-glycerphosphate and activated sodium orthovanadate. Whole muscle were 
lysed in the same buffer using a gentleMACS™ Dissociators (Miltenyi Biotec) in 
combination with M Tubes, to homogenize the tissue. 30 μg of total protein extract were 
resolved in Laemmli buffer by SDS-PAGE on pre-cast gels (Bio-Rad) and transferred to 
polyvinylidene fluoride (PVDF) membranes. Membranes were blocked for 30 min in 5% 
non-fat milk in TBS-0.05% Tween buffer. Primary antibodies against pERK1/2 (1:1000), 
total ERK1/2 (1:1000), pax7 (1:250), MHC (1:200), OTR (1:2000), β-Actin (1:1000) were 
diluted in 5% non-fat milk in TBS-0.05% Tween buffer. PVDF membranes were incubated 
in antibody solutions overnight at 4°C. HRP-conjugated secondary antibodies were diluted 
1:4000 in 5% non-fat milk in TBS-0.05% Tween buffer and membranes were incubated for 
2 hours at room temperature. Blots were subsequently developed using Amersham ECL Plus 
(GE Healthcare), and analyzed with a Bio-Rad Gel Doc/Chemi Doc Imaging System. 
Quantifications were done using Image J.
RNA isolation and Real-time RT-PCR
RNA isolation was performed using an RNAeasy Mini Kit (Qiagen) according to 
manufacturer’s recommendations. Reverse transcription (RT) was performed using 
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SuperScript III First-Strand Synthesis System (Invitrogen). Real-time PCR was performed 
with Biorad iQ5 real-time PCR. Primers used are as follow: GAPDH-F 5′-
CCACTTGAAGGGTGGAGCCA-3′; GAPDH-R 5′-TCATGGATGACCTTGGCCAG-3′; 
p21-F 5′-GCCCGAGAACGGTGGAACTT-3′; p21-R 
5′GACAAGGCCACGTGGTCCTC-3′.
Muscle histology
We used an injury model consisting of a focal injection of cardiotoxin in the Gastrocnemius 
(GA) or the Tibialis anterior (TA) muscle. Muscles were dissected 3 or 5 days post injury 
and placed in 25% sucrose in PBS at 4 °C for 4 hours. Muscle samples were then quickly 
rinsed and frozen in Tissue-Tek OCT for cryosectioning. 10 μm cross-sections were stained 
with Hematoxylin and Eosin or Richard-Allan Scientific Gomori trichrome (Thermo 
Scientific) for histology analysis.
Immunocytochemistry
Cells or muscle sections were fixed for 20 minutes in 4% PFA, permeabilized with 0.25% 
Triton-X-100 in staining buffer (0.1% Sodium Azide and 1% Bovine Growth Serum in PBS) 
for 15 minutes, and incubated with primary antibody diluted in staining buffer overnight at 4 
°C. Primary antibodies were diluted as following: BrdU: 1:200; Desmin: 1:200; Dystrophin: 
1:200; eMyHC: 1:200; Ki67: 1:200; Myf5: 1:100; OTR: 1:100; Pax7: 1:20; Perilipin: 1:250. 
Cells or muscle sections were washed with staining buffer and incubated with an Alexa-
Fluor conjugated secondary antibody (1:2000, Invitrogen) in staining buffer for 2 hours at 
room temperature, washed with staining buffer, and slides were mounted with ProLong 
Gold antifade reagent with DAPI (P36935, Invitrogen). An additional incubation with HCl 
2.5 M for 30 minutes was performed before the permeabilization step when cells were 
stained for BrdU.
Chemicals and antibodies
OTA desGly-NH2-d(CH2)5[D-Tyr2,Thr4]OVT is a potent OT-selective antagonist kindly 
provided by Pr. Maurice Manning from the University of Toledo49,50. OT was purchased 
from Bachem (H-2510). MEK inhibitor UO126 was purchased from Cell Signaling (9903) 
and PD98059 from Tocris (1213). Antibody against eMyHC (F1.652) and Pax7 were 
purchased from Developmental Studies Hybridoma Bank. Anti-OTR antibody was 
purchased from Proteintech (23045-1-AP). Antibody against Desmin (ab15200), Ki67 
(ab15580), BrdU (ab6326) and Dystrophin (ab3149) were purchased from Abcam. 
Antibodies against Phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) and p44/42 MAPK 
(ERK1/2) and β-Actin were purchased from Cell Signaling (4370, 4696, and 4967 
respectively). Anti-Perilipin A/B antibody was purchased from Sigma-Aldrich (P1873) and 
antibody against Myf5 and MHC were purchased from Santa Cruz (SC-302 and SC-20641 
respectively). Fluorophore-conjugated secondary antibodies (Alexa Fluor) were purchased 
from Invitrogen. HRP-conjugated secondary antibodies were purchased from Santa Cruz 
Biotechnologies.
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Fiber size
Fiber surface area and Feret minimum diameter were measure using Image J software on 
hematoxylin and eosin stained muscle cross sections.
Fibrosis quantification
Fibrosis was quantified as previously described 5. Briefly, gastrocnemius muscle cross 
sections were immunostained for eMyHC. The total injured area and the fiber area of all 
eMyHC-positive fibers were measured using Image J software. The “Fibrotic Index” was 
calculated as: (1 − (total eMyHC+ fibers area / total injury area)) × 100%.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Systemic oxytocin declines with age and oxytocin receptor is expressed in skeletal 
muscle satellite cells
a, OT plasmatic levels were quantified by Enzyme Immunoassay in young (2-4 month old) 
and aged (18-24 month old) C57BL/6 male mice. Data represent mean ± SEM (n=6 young 
versus n=7 old). Two-tailed unpaired Student’s t test **: p value < 0.01.
b and c, Whole skeletal muscle (GA) protein extracts (b), and hind limb satellite cell protein 
extracts (c) were prepared from young and old non-injured mice. Oxytocin receptor (OTR), 
Pax7, and myosin heavy chain (MHC) were assayed by western blot analysis. 30 μg of 
protein were loaded per lane and β-actin was used as a loading control. In b and c, Y-SKM: 
young skeletal muscle; O-SKM: old skeletal muscle; Y-SC: young satellite cell; O-SC: old 
satellite cell.
d and e, Quantification of western blot from b, and c, using Image J software. Data represent 
mean +/− SEM (n=4 Y-SKM, n=4 O-SKM, n=3 Y-SC, and n=3 O-SC). Two-tailed unpaired 
Student’s t test *: p value < 0.05.
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f, Cross sections from non-injured and 3 day-injured tibialis anterior muscle were 
immunostained for OTR and dystrophin or OTR and Pax7, as indicated, and counterstained 
with DAPI. IgG control are displayed (bottom) and dashed lines delineate muscle fibers. 
Scale bars represent 20 μm.
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Figure 2. Age-specific systemic oxytocin decline plays a key role in the defective muscle 
regeneration observed upon aging
a, Schematic of the experimental procedure. Cardiotoxin (CTX) muscle injury was 
performed at day 0. Four days before muscle injury and over the course of the experiment, 
mice were administered OT (1 μg g−1 of mice), OTA (2 μg g−1 of mice), or vehicle (HBSS) 
daily. Five days after muscle injury, mice were killed and (GA) muscles were dissected. 10 
μm cross sections were stained for hematoxylin and eosin (H&E).
b, Hematoxylin and eosin (H&E) (top) and eMyHC (bottom) staining of cardiotoxin-injured 
gastrocnemius muscle cross sections from mice injected with OT, OTA, or vehicle (HBSS). 
Scale bars represent 50 μm.
c, Muscle regeneration was quantified by scoring the number of newly-formed fibers 
(eMyHC positive fibers with centrally-located nuclei) in the injured area of gastrocnemius 
cross sections. Data represent mean ± SEM (n=9 YV, n=5 OV, n=6 YOT, n=6 OOT, n=5 
Elabd et al. Page 16
Nat Commun. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
YOTA). One-way ANOVA with post-hoc Newman-Keuls test **: p value < 0.01, ***: p 
value < 0.001, NS: Not Significant.
d, Fibrosis quantification of gastrocnemius muscle cross sections 5 days after injury. The 
fibrotic index represents the percentage of the injury area occupied by connective tissue. 
Data represent mean ± SEM (n=3 YV, n=3 OV, n=3 YOT, n=3 OOT, n=3 YOTA). One-
way ANOVA with post-hoc Newman-Keuls test *: p value < 0.05, **: p value < 0.01, NS: 
Not Significant.
In b-d, YOTA: Young injected with OTA; YOT: Young injected with OT; YV: Young 
injected with vehicle, OV: Old injected with vehicle; OOT: Old injected with OT.
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Figure 3. Oxytocin improves muscle stem cell proliferation in vivo after injury
a, Schematic of the experimental procedure. Cardiotoxin (CTX) muscle injury was 
performed at day 0. Six days before muscle injury and over the course of the experiment, 
mice were administered OT (1 μg g−1 of mice), or vehicle (HBSS) daily. Twelve hours prior 
to euthanasia, mice were administered with BrdU (50 μg g−1 of mice, IP). Three days after 
muscle injury, tibialis anterior (TA) muscles were isolated.
b, Representative micrographs of 3-day-injured TA muscle cross sections (10 μm) 
immunostained for BrdU and Desmin and counterstained with DAPI. Right panels represent 
magnifications of the dashed area from left panels. White arrow indicates a BrdU and 
Desmin double positive cell, yellow and white arrowheads indicate BrdU or Desmin single 
positive cells, respectively. Scale bars represent 100 μm (left panels) and 50 μm (right 
panels).
c, Quantification of the percentage of proliferating myogenic cells (Desmin+ and BrdU+). 
Data represent mean ± SEM (n=4 YV, n=4 OV, n=4 OOT), one-way ANOVA with post-hoc 
Newman-Keuls test *: p value < 0.05, **: p value < 0.01.
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Figure 4. Oxytocin rejuvenates muscle stem cell function in injured tissue
a, Schematic of the experimental procedure. Cardiotoxin (CTX) muscle injury was 
performed at day 0. Six days before muscle injury and over the course of the experiments, 
mice were administered OT (1 μg g−1 of mice), OTA (2 μg g−1 of mice), or vehicle (HBSS) 
daily. Twelve hours prior to euthanasia, mice were administered with BrdU (50 μg g−1 of 
mice, IP). Three days after muscle injury, GA and TA muscles were isolated and digested 
into bulk fibers. Cells were cultured in their mouse’s respective sera (shortened as “own” on 
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the schematic) for 24 hours and either fixed and stained for Desmin and BrdU or induced to 
differentiate for 48 hours and subsequently fixed and stained for eMyHC.
b and c, Myogenic cell proliferation. Muscle fiber associated activated satellite cells were 
isolated 3 days after injury from mice injected with OT, OTA, or vehicle (HBSS), plated in 
media containing their mouse’s respective sera and fixed 24 hours after plating. b, 
Representative micrographs of cells immunostained for Desmin and BrdU and 
counterstained with DAPI. Scale bars represent 50 μm. c, Quantification of the percentage of 
proliferating myogenic cells (Desmin+ and BrdU+). Data represent mean ± SEM (n=6 YV, 
n=3 OV, n=3 YOT, n=3 OOT, n=5 YOTA).
d and e, Myogenic fusion index. Muscle fiber associated activated satellite cells were 
isolated 3 days after injury from mice injected with OT, OTA, or vehicle (HBSS), and plated 
in media containing their mouse’s respective sera for 24 hours. Cells were then induced to 
differentiate in mitogen-low fusion medium for 48 hours, fixed and immunostained for 
eMyHC using DAPI to label all nuclei. d, Representative micrographs. Scale bar represents 
50 μm. e, Quantification of the percentage of nuclei in eMyHC+ myotubes. Data represent 
mean ± SEM (n=8 YV, n=5 OV, n=6 YOT, n=6 OOT, n=5 YOTA). In b-e YOTA: Young 
injected with OTA; YOT: Young injected with OT; YV: Young injected with vehicle, OV: 
Old injected with vehicle; OOT: Old injected with OT. One-way ANOVA with post-hoc 
Newman-Keuls test *: p value < 0.05, **: p value < 0.01, ***: p value < 0.001, NS: Not 
Significant.
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Figure 5. Oxytocin improves myogenic progenitor cell proliferation via activation of the 
MAPK/ERK pathway
a and b, Activated satellite cells were isolated 3 days after injury from young or old mice, 
cultured for 24 hours in media containing their own mouse’s respective sera supplemented 
with OT (30 nM), PD98059 MEK inhibitor (50 μM), or OT plus MEK inhibitor, fixed and 
stained for Ki67 and counterstained for DAPI. a, Representative micrographs. Scale bars 
represent 200 μm. b, Quantification of the percentage of proliferating (Ki67+) satellite cells. 
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Data represent mean ± SEM (n=4 mice per group). Two-way ANOVA with post-hoc 
Bonferroni test **: p value < 0.01, ***: p value < 0.001, NS: Not Significant.
c, p21 mRNA relative expression analyzed by qRT-PCR. RNA was extracted from satellite 
cells isolated and cultured as in a. GAPDH was used as reference gene (n=3 mice per 
group). Two-way ANOVA with post-hoc Bonferroni test **: p value < 0.01, ***: p value < 
0.001, NS: Not Significant.
d and e, Primary myogenic progenitors were cultured in the presence or absence of OT (30 
nM), and UO126 MEK inhibitor (10 μM) for 48 hours. BrdU was added to the culture 
medium during the last hour. Cells were then fixed, immunostained for BrdU and 
counterstained with DAPI. d, Representative micrographs. Scale bars represent 50 μm. e, 
The percentages of BrdU positive cells were scored. Data represent mean ± SEM (n= 8 
independent experiment performed on different primary cultures). One-way ANOVA with 
post-hoc Newman-Keuls test ***: p value < 0.001, NS: Not Significant.
f, Primary myogenic progenitors were serum starved overnight then treated with OT (30 
nM), or OT (30 nM) plus UO126 MEK inhibitor (10 μM) for up to 20 minutes. ERK1/2 and 
phospho-ERK1/2 were assayed by western blot analysis. O: OT, OM: OT plus UO126 MEK 
inhibitor.
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Figure 6. Impaired muscle regeneration in mice lacking oxytocin
a, Hematoxylin and eosin staining (H&E) (top) and eMyHC (bottom) of cardiotoxin-injured 
gastrocnemius muscle cross sections from 12-month-old wild type (WT) and Ot knockout 
(KO) mice. Scale bars represent 50 μm.
b, Muscle regeneration quantification of 3-month-old and 12-month-old WT or Ot KO mice 
was performed by scoring the number of newly-formed fibers (eMyHC positive fibers with 
centrally-located nuclei) in the injured area of gastrocnemius cross sections. Data represent 
mean ± SEM (n=6 WT and n=4 KO for the 3 month old mice, n=4 WT and n=5 KO for the 
12 month old). Two-way ANOVA with post-hoc Bonferroni test *: p value < 0.05, NS: Not 
Significant.
c, Quantification of the percentage of proliferating myogenic cells (Desmin+ and BrdU+) of 
3-day-injured TA muscle cross sections immunostained for BrdU and Desmin. Data 
represent mean ± SEM (n=5 WT, n=5 KO). Two-tailed unpaired Student’s t test *: p value < 
0.05.
d, Fibrosis quantification of gastrocnemius muscle cross sections 5 days after injury. The 
fibrotic index represents the percentage of the injury area occupied by connective tissue. 
Data represent mean ± SEM (n=4 WT and n=4 KO). Two-tailed unpaired Student’s t test *: 
p value < 0.05.
e, Representative micrograph of perilipin immunostaining on 5-day-cardiotoxin-injured 
gastrocnemius muscle cross section. Scale bar represents 50 μm.
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f and g, Adipocyte numbers (perilipin positive cells) per injured (f) or un-injured (g) area 
from WT and Ot KO mice. Data represent mean ± SEM (n=3 WT and n=5 KO). Two-tailed 
unpaired Student’s t test, NS: Not Significant.
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Figure 7. Mice lacking oxytocin develop premature sarcopenia
a, Representative photographs of Ot KO and WT mice hind limb skeletal muscles (right leg) 
after the skin was carefully removed (WT and KO mice are presented side by side on each 
photograph). Visualization of perimuscular adipose tissue deposition (arrows) and of 
exposed intermuscular adipose tissue (arrowheads). (i) Ventral view, arrows indicate the 
adipose tissue on the internal part of the quadriceps. The star shows that Ot KO mice display 
increased posterior subcutaneous adipose tissue. (ii) Ventral view showing adipose tissue 
deposition over the quadriceps (top arrows) and the tibialis anterior (bottom arrows). (iii) 
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Lateral view showing adipose tissue deposition covering the quadriceps (top arrows) and the 
tibialis anterior and gastrocnemius (bottom arrows). (iv) Dorsal view showing the 
intermuscular adipose tissue deposition of the hind leg (arrowheads) and the adipose tissue 
covering the gastrocnemius muscle (arrows). As compared to the WT littermates, the KO 
mice have an increase in fat tissue in all the studied muscle groups, and visibly reduced 
muscle, which is studied in more detail and quantified below.
b, TA and c, GA muscles from 12-month-old WT or Ot KO mice were weighed. Data 
represent mean ± SEM (top), representative pictures (bottom). Two-tailed unpaired 
Student’s t test *: p value < 0.05, ***: p value < 0.001, n=5 WT and n=10 KO mice.
d, The surface area and e, The minimum Feret’s diameter were measured using WT and Ot 
KO muscle cross section stained with Hematoxylin and eosin. Data represent mean ± SEM 
(n=4 mice per group), two-way ANOVA with post-hoc Bonferroni test *: p value < 0.05, **: 
p value < 0.01, NS: Not Significant.
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